Literature DB >> 10781942

Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development.

J Götz1, A Probst, C Mistl, R M Nitsch, E Ehler.   

Abstract

Protein phosphatase 2A (PP2A) plays central roles in development, cell growth and transformation. Inactivation of the gene encoding the PP2A catalytic subunit Calpha by gene targeting generates a lethal embryonic phenotype. No mesoderm is formed in Calpha(-/-) embryos. Here, we found that during normal early embryonic development Calpha was predominantly present at the plasma membrane whereas the highly homologous isoform Cbeta was localized to the cytoplasm and nuclei, suggesting the inability of Cbeta to compensate for vital functions of Calpha in Calpha(-/-) embryos. In addition, PP2A was found in a complex containing the PP2A substrates E-cadherin and beta-catenin. In Calpha(-/-) embryos, E-cadherin and beta-catenin were redistributed from the plasma membrane to the cytosol. Cytosolic concentrations of beta-catenin were low. Our results suggest that Calpha is required for stabilization of E-cadherin/beta-catenin complexes at the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781942     DOI: 10.1016/s0925-4773(00)00267-7

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  22 in total

Review 1.  PP2A as a master regulator of the cell cycle.

Authors:  Nathan Wlodarchak; Yongna Xing
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-02-24       Impact factor: 8.250

2.  Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution.

Authors:  Jin Zhou; Huong T Pham; Ralf Ruediger; Gernot Walter
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

3.  Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions.

Authors:  Mihai Nita-Lazar; Ivan Rebustini; Janice Walker; Maria A Kukuruzinska
Journal:  Exp Cell Res       Date:  2010-02-13       Impact factor: 3.905

4.  Confluence induced threonine41/serine45 phospho-beta-catenin dephosphorylation via ceramide-mediated activation of PP1cgamma.

Authors:  Norma Marchesini; Jeffrey A Jones; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2007-11-08

5.  Specificity of RCN1-mediated protein phosphatase 2A regulation in meristem organization and stress response in roots.

Authors:  Joshua J Blakeslee; Hong-Wei Zhou; Jeffrey T Heath; Kyle R Skottke; Jorge A Rodriguez Barrios; Su-Yang Liu; Alison DeLong
Journal:  Plant Physiol       Date:  2007-12-27       Impact factor: 8.340

6.  Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice.

Authors:  Stefan Kins; Pascal Kurosinski; Roger M Nitsch; Jürgen Götz
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  Protein phosphatase 2A Cα regulates proliferation, migration, and metastasis of osteosarcoma cells.

Authors:  Di Yang; Hirohiko Okamura; Hiroyuki Morimoto; Jumpei Teramachi; Tatsuji Haneji
Journal:  Lab Invest       Date:  2016-09-12       Impact factor: 5.662

Review 8.  The role of PP2A A subunits in tumor suppression.

Authors:  Anna A Sablina; William C Hahn
Journal:  Cell Adh Migr       Date:  2007-07-05       Impact factor: 3.405

9.  Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model.

Authors:  Zoltán Nagy; Kornélia Baghy; Éva Hunyadi-Gulyás; Tamás Micsik; Gábor Nyírő; Gergely Rácz; Henriett Butz; Pál Perge; Ilona Kovalszky; Katalin F Medzihradszky; Károly Rácz; Attila Patócs; Peter Igaz
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

10.  Protein phosphatase 2A activity is required for functional adherent junctions in endothelial cells.

Authors:  Anita Kása; István Czikora; Alexander D Verin; Pál Gergely; Csilla Csortos
Journal:  Microvasc Res       Date:  2013-05-28       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.